Erythromelalgia News and Research

RSS

New project investigates impact of thymectomy as treatment for MuSK myasthenia gravis

The American Association of Neuromuscular & Electrodiagnostic Medicine is honoring Katherine Clifford, BA, with the 2018 Golseth Young Investigator Award for her abstract, Thymectomy is Not Associated With Clinical Improvement in a Multi-Center Cohort of Patients with Anti-MuSK Myasthenia Gravis.

3 Sep 2018

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announced today that the US Food and Drug Administration has granted orphan-drug designation to the investigational drug XEN402 being developed for the treatment of pain associated with erythromelalgia.

24 Apr 2013

Single mutation in a human sodium channel gene can trigger pain in people with primary erythromelalgia

Yale School of Medicine researchers report the first demonstration that a single mutation in a human sodium channel gene can trigger pain in people with an inherited pain syndrome known as primary erythromelalgia, according to a study published this month in the journal Brain.

13 Jul 2005